Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kiely John, Director. Insider active across 2 companies, notably Amneal Pharmaceuticals, Inc.. Aggregated, 14 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €1.5m. Activity tracked since 29 March 2022. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kiely John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
50,000 shares@ US$17.64Class A Common StockSEC:0001628280-26-057147:0
10,000 shares0Class A Common StockSEC:0001628280-26-057147:1
32,000 shares@ US$9.2329.4% of flowClass A Common StockSEC:0001781149-25-000006:0
50,000 shares@ US$7.5956.2% of flowClass A Common StockSEC:0001628280-25-025140:0
40,258 sharesClass A Common StockSEC:0001628280-25-023991:0
28,506 shares@ US$4.7621.3% of flowClass A Common StockSEC:0001628280-24-049297:0
17,058 shares@ US$8.3822.5% of flowClass A Common StockSEC:0001628280-24-049297:1
76,453 sharesClass A Common StockSEC:0001628280-24-023252:0
80,128 sharesClass A Common StockSEC:0001209191-23-028735:0
8,855 sharesCommon StockSEC:0001567619-22-017003:0
35,406 sharesClass A Common StockSEC:0001209191-22-028157:0
16,410 shares0Common StockSEC:0001567619-22-007792:0
8,855 sharesCommon StockSEC:0001567619-21-016660:0
46,218 sharesClass A Common StockSEC:0001209191-21-030809:0
About Kiely John
Kiely John is Administrateur at Amneal Pharmaceuticals, Inc. (XNAS) and Zovio Inc (XNAS). He has 12 filings in total, and across the recent sampled filings, the transactions span 2021-05-07 to 2025-08-28, with EUR 0 of buys and EUR 732138 of sells, the most common transaction nature being Levée d'options.